威高骨科
(688161)
| 流通市值：107.96亿 | | | 总市值：107.96亿 |
| 流通股本：4.00亿 | | | 总股本：4.00亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 296,330,838.73 | 1,522,794,046.97 | 1,106,261,911.75 | 740,917,209.72 |
| 营业收入 | 296,330,838.73 | 1,522,794,046.97 | 1,106,261,911.75 | 740,917,209.72 |
| 二、营业总成本 | 253,047,152.6 | 1,208,242,886.13 | 863,391,351.16 | 562,087,567.47 |
| 营业成本 | 117,115,903.52 | 534,831,637.27 | 391,417,809.22 | 248,195,913.11 |
| 税金及附加 | 3,869,748.98 | 22,919,684.18 | 15,948,550.42 | 10,679,772.97 |
| 销售费用 | 80,750,419.66 | 422,917,315.58 | 292,240,112.98 | 196,274,711.36 |
| 管理费用 | 26,446,489.88 | 124,834,344.99 | 89,137,927.25 | 56,226,364.51 |
| 研发费用 | 25,069,791.47 | 112,298,962.56 | 83,965,184.77 | 58,209,611.09 |
| 财务费用 | -205,200.91 | -9,559,058.45 | -9,318,233.48 | -7,498,805.57 |
| 其中:利息费用 | 133,793.45 | 975,388.37 | 75,189.44 | 53,124.22 |
| 其中:利息收入 | 1,958,497.89 | 15,236,419.91 | 12,420,842.31 | 9,347,435.11 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -270,473.98 | 1,247,084.46 | 1,154,401.1 | 1,293,498.22 |
| 加:投资收益 | 6,198,148.98 | 30,924,370.7 | 23,471,286.38 | 14,943,618.92 |
| 资产处置收益 | 16,407.27 | 146,849.42 | 8,619.45 | - |
| 资产减值损失(新) | -3.74 | -32,272,551.75 | -25,591,336.96 | -25,992,797.73 |
| 信用减值损失(新) | -944,160.29 | -7,285,091.61 | -2,877,394.73 | -1,093,991.67 |
| 其他收益 | 4,268,109.58 | 16,105,271.23 | 13,193,452.12 | 7,361,134.58 |
| 四、营业利润 | 52,551,713.95 | 323,417,093.29 | 252,229,587.95 | 175,341,104.57 |
| 加:营业外收入 | 56,017.47 | 1,644,299.51 | 65,517.82 | 45,764.8 |
| 减:营业外支出 | 2,375.28 | 995,650.4 | 526,606.32 | 506,226.5 |
| 五、利润总额 | 52,605,356.14 | 324,065,742.4 | 251,768,499.45 | 174,880,642.87 |
| 减:所得税费用 | 9,291,818.44 | 50,261,004.73 | 40,594,372.77 | 30,249,174.23 |
| 六、净利润 | 43,313,537.7 | 273,804,737.67 | 211,174,126.68 | 144,631,468.64 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 43,313,537.7 | 273,804,737.67 | 211,174,126.68 | 144,631,468.64 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 44,229,577.44 | 268,643,514.62 | 207,405,739 | 141,957,058.61 |
| 少数股东损益 | -916,039.74 | 5,161,223.05 | 3,768,387.68 | 2,674,410.03 |
| 扣除非经常损益后的净利润 | 40,867,094.09 | 254,674,965.84 | 194,444,725.63 | 135,796,706.88 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.11 | 0.68 | 0.52 | 0.35 |
| (二)稀释每股收益 | 0.11 | 0.67 | 0.52 | 0.35 |
| 九、综合收益总额 | 43,313,537.7 | 273,804,737.67 | 211,174,126.68 | 144,631,468.64 |
| 归属于母公司股东的综合收益总额 | 44,229,577.44 | 268,643,514.62 | 207,405,739 | 141,957,058.61 |
| 归属于少数股东的综合收益总额 | -916,039.74 | 5,161,223.05 | 3,768,387.68 | 2,674,410.03 |
| 公告日期 | 2026-04-30 | 2026-03-28 | 2025-10-31 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |